Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice

BACKGROUND: Molecular analysis of KIT and PDGFRA is critical for tyrosine kinase inhibitor treatment selection of gastrointestinal stromal tumors (GISTs) and hence recommended by international guidelines. We performed a nationwide study into the application of predictive mutation testing in GIST pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Steeghs, Elisabeth M. P., Gelderblom, Hans, Ho, Vincent K. Y., Voorham, Quirinus J. M., Willems, Stefan M., Grünberg, Katrien, Ligtenberg, Marjolijn J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338807/
https://www.ncbi.nlm.nih.gov/pubmed/33909171
http://dx.doi.org/10.1007/s10120-021-01190-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338807/
https://www.ncbi.nlm.nih.gov/pubmed/33909171
http://dx.doi.org/10.1007/s10120-021-01190-9

Ejemplares similares